Defects in ryanodine receptor calcium release in skeletal muscle from post-myocardial infarct rats

C W Ward1, S Reiken, A R Marks

  • 1Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, USA.

Insights

Post-myocardial infarction (PMI) impairs skeletal muscle function by altering calcium (Ca2+) signaling. This study reveals ryanodine receptor 1 (RyR1) hyperphosphorylation and FKBP12 depletion in PMI skeletal muscles, contributing to exercise intolerance.

Area of Science:

  • Physiology
  • Molecular Biology
  • Cardiovascular Research

Background:

  • Skeletal muscle dysfunction and reduced exercise capacity are common in patients with heart disease.
  • The molecular mechanisms linking cardiac dysfunction to skeletal muscle defects, particularly calcium (Ca2+) handling, remain unclear.

Purpose of the Study:

  • To investigate alterations in skeletal muscle Ca2+ signaling and the ryanodine receptor 1 (RyR1) in a rat model of post-myocardial infarction (PMI).
  • To identify molecular changes in RyR1 that may underlie impaired muscle function following cardiac injury.

Main Methods:

  • Utilized a rat post-myocardial infarction (PMI) model to induce myocardial overload.
  • Assessed global and local Ca2+ signaling in skeletal muscle fibers using multiphoton imaging.
  • Analyzed Ca2+ transients, Ca2+ sparks, RyR1 phosphorylation, and FKBP12 levels in extensor digitorum longus (EDL) muscles.

Main Results:

  • PMI skeletal muscle fibers exhibited significantly reduced Ca2+ transient amplitude and prolonged duration.
  • Spontaneous Ca2+ sparks in isolated PMI EDL fibers showed altered spatio-temporal properties.
  • Skeletal muscle RyR1 from PMI rats was hyperphosphorylated by PKA and depleted of FKBP12.

Conclusions:

  • Post-myocardial infarction leads to significant alterations in skeletal muscle local Ca2+ signaling, specifically affecting RyR1 function.
  • Hyperphosphorylation of RyR1 and FKBP12 depletion in skeletal muscle are key molecular changes associated with cardiac dysfunction.
  • These Ca2+ signaling defects likely contribute to impaired excitation-contraction coupling and reduced exercise capacity in PMI, exceeding the expected level based on cardiac function alone.